scispace - formally typeset
P

Palani Gunasekaran

Researcher at King Institute of Preventive Medicine and Research

Publications -  47
Citations -  2258

Palani Gunasekaran is an academic researcher from King Institute of Preventive Medicine and Research. The author has contributed to research in topics: Virus & Apoptosis. The author has an hindex of 23, co-authored 46 publications receiving 1882 citations.

Papers
More filters
Journal ArticleDOI

Green biosynthesis of silver nanoparticles from Annona squamosa leaf extract and its in vitro cytotoxic effect on MCF-7 cells

TL;DR: In this article, a biological method for the synthesis of silver nanoparticles (AgNPs) using Annona squamosa leaf extract and its cytotoxicity against MCF-7 cells are reported.
Journal ArticleDOI

Cytotoxic effect of Green synthesized silver nanoparticles using Melia azedarach against in vitro HeLa cell lines and lymphoma mice model

TL;DR: In vivo DAL mice model showed significant increase in life span, induction of apoptosis was evidenced by acridine orange and ethidium bromide staining, and Cytotoxicity of biosynthesized AgNPs against in vitro Human epithelial carcinoma cell line (HeLa) showed a dose–response activity.
Journal ArticleDOI

Correction: Corrigendum: Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy

TL;DR: This research presents a novel probabilistic procedure called “spot-spot analysis” that allows for direct measurement of the response of the immune system to chemotherapy-like substances.
Journal ArticleDOI

Multifunctional HER2-Antibody Conjugated Polymeric Nanocarrier-Based Drug Delivery System for Multi-Drug-Resistant Breast Cancer Therapy

TL;DR: This nanocarrier drug delivery system (DDS) not only actively targets a multidrug-resistance (MDR) associated phenotype (HER2 receptor overexpression) but also improves therapeutic efficiency by enhancing the cancer cell targeted delivery and sustained release of therapeutic agents.